Interested in participating in Clinical Trial Studies?
Fill out our quick Pre-Screening Questionnaire below
Active Clinical Trial Studies
Clinical Trial Studies available to participants
Clinical Trial Studies and those who contribute play a role in the development of new treatments for some of our most common and debilitating diseases and conditions.
Patients who participate in Excell’s clinical trial studies have an opportunity to join the vanguard of scientific research and contribute to the progress, knowledge, and future treatment of psychiatric or medical conditions.
We will provide you with comprehensive information and straightforward answers to your questions regarding the risks and benefits of participating.
Financial compensation may be available to those who qualify and complete visits for clinical trial studies at Excell.
Sign up for a clinical trial study trial today!
Depression Clinical Trial Studies
Clinical Trial Studies Available:
Summary: Depression/MDD clinical trials are generally focused on researching new investigational therapies and adjunctive therapies for treating those suffering from depression. The objective of this research is to identify new investigational therapies which may have less side-effects, better performance, and provide improved clinical outcomes compared to existing medications on the market.
Eligibility Criteria
Key Inclusion Criteria:
- Symptoms of depression for at least 6 weeks prior to entering the study.
- Willing to comply with all study assessments and procedures.
Key Exclusion Criteria:
- Diagnosed with bi-polar disorder, schizophrenia, psychotic disorders, or dementia.
- Clinically significant medical conditions.
- History of substance abuse in the past 3 months.
Patient Time Reimbursed?
Yes
Patient Travel Reimbursed?
Yes
Age:
18-75
Generalized Anxiety Clinical Trial Studies
Clinical Trial Studies Available:
Summary: Generalized Anxiety Disorder clinical trials aim to research investigational therapies for the aforementioned indications. Millions of people suffer from anxiety and it continues to become a growing trend within the general population.
Eligibility Criteria:
Key Inclusion Criteria:
- Male or female subject over the age of 18
- Currently experiencing symptoms of Generalized Anxiety Disorder
- Primary focus of treatment is Generalized Anxiety Disorder.
Key Exclusion Criteria:
- Diagnosis other than Generalized Anxiety Disorder that was the primary focus of treatment within 12 months before Screening.
- Any clinically significant unstable medical condition or any clinically significant chronic disease, that would limit the subject’s ability to complete and/or participate in the study.
Patient Time Reimbursed?
Yes
Patient Travel Reimbursed?
Yes
Age:
18 and above
Schizophrenia Clinical Trial Studies
Clinical Trial Studies Available:
Summary: Schizophrenia clinical trials explore new treatments and therapies to improve the quality of life for individuals living with the condition. Participants may gain access to cutting-edge care, contribute to medical advancements, and receive compensation for their time. Trials typically involve diagnostic evaluations, medication or therapy protocols, and regular monitoring by medical professionals. Eligibility criteria vary, so interested individuals should consult with the trial coordinators to determine if they qualify.
Eligibility Criteria
Key Inclusion Criteria:
- Diagnosed with Schizophrenia
- Willing to comply with all study assessments and procedures.
- Some studies may require participants to be taking an antipsychotic medication for a period of time prior to participating
Key Exclusion Criteria:
- Diagnosed with bi-polar disorder or other non-schizophrenic psychotic disorders.
- Current substance/alcohol abuse.
- Clinically significant medical conditions.
Patient Time Reimbursed?
Yes
Patient Travel Reimbursed?
Yes
Age:
18-65
Social Anxiety Clinical Trial Studies
Clinical Trial Studies Available:
Summary Trial A: The study’s purpose is to evaluate the efficacy and safety of Fasedienol as monotherapy compared to placebo in subjects with Social Anxiety Disorder. The investigational medication is in the form of a nasal spray.
Summary Trial B: The study’s purpose is to evaluate the efficacy and safety of BNC210 as monotherapy compared to placebo in subjects with Social Anxiety Disorder. The investigational medication is in the form of a tablet.
Eligibility Criteria:
Key Inclusion Criteria:
- Currently experiencing symptoms of social anxiety disorder.
- Willing to stop exclusionary psychiatric medications prior to study entry.
Key Exclusion Criteria:
- Lifetime history of bi-polar disorder, schizophrenia, borderline personality disorder or autism spectrum disorders.
- Unwilling to discontinue exclusionary medications or comply with study procedures.
- Any clinically significant unstable medical condition or any clinically significant chronic disease.
Patient Time Reimbursed?
Yes
Patient Travel Reimbursed?
Yes
Age:
18 to 65
Adolescent Migraine Clinical Trial Studies
Clinical Trial Studies Available:
Summary: Adolescent migraine clinical trials study new treatments to reduce the frequency and severity of migraines in teens. Participants may gain access to advanced care, contribute to research, and often receive compensation. Trials typically involve evaluations, medication or therapy protocols, and regular monitoring by healthcare professionals. Eligibility varies, so families should consult trial coordinators for details.
Eligibility Criteria
Key Inclusion Criteria:
- History of migraines for at least 6 months.
- History of more than 1 migraine per month.
Key Exclusion Criteria:
- Any clinically significant hematologic, endocrine, pulmonary, renal, hepatic, gastrointestinal, cardiovascular, or neurologic disease.
- Other confounding pain syndromes, confounding psychiatric conditions, or other significant neurological disorders other than migraine.
Patient Time Reimbursed?
Yes
Patient Travel Reimbursed?
Yes
Age:
12-17
- Quick Form to See if you Qualify for our Clinical Trial Studies
Pre-screening Clinical Trial Studies questionnaire and your privacy
Please be advised that by filling out the study pre-screening questionnaire, you will be asked to provide personal information, including age, gender, and your current medical condition. One of our staff will then reach out to conduct a phone-screen to see if you qualify for one of our current studies at our office location in Oceanside, CA. Your privacy is of the utmost importance to Excell Research therefore our privacy will be protected and the information you provide will only be shared with those involved with the clinical research study if it is determined that you may be eligible to participate, unless you permit us to do so or except as required by law. Your information will not be sold to outside companies, nor will it be stored or collected without your direct consent.
Many pharmaceutical companies and Excell Research are conducting these studies under the Food and Drug Administration (FDA) to learn more about new investigational drugs or treatments. Read our privacy policy to learn more about how your information will be kept private.